• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS-CoV-1 survivors after two doses of CoronaVac

tetano

Editor, Senior Moderator
J Med Virol


. 2023 Oct;95(10):e29136.
doi: 10.1002/jmv.29136. Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS-CoV-1 survivors after two doses of CoronaVac plus one dose subunit vaccine

Danying Chen[SUP] 1 2 3 4 [/SUP], Xinglin Li[SUP] 1 2 3 4 [/SUP], Xiaohua Hao[SUP] 1 3 [/SUP], Yaruo Qiu[SUP] 1 2 5 [/SUP], Yanjun Song[SUP] 1 2 3 4 [/SUP], Hui Sun[SUP] 1 2 3 4 [/SUP], Yongmei Liu[SUP] 1 2 3 4 [/SUP], Juan Du[SUP] 1 2 3 4 [/SUP], Yuanyuan Zhang[SUP] 1 2 3 4 [/SUP], Fan Xiao[SUP] 1 2 3 4 [/SUP], Chuan Song[SUP] 1 2 3 4 [/SUP], Yonghong Yan[SUP] 1 2 3 4 [/SUP], Rui Song[SUP] 1 3 [/SUP], Xi Wang[SUP] 1 2 3 4 [/SUP], Xuesen Zhao[SUP] 1 2 3 4 [/SUP], Ronghua Jin[SUP] 1 2 3 4 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron harbors more than 30 mutations of the spike protein and exhibits substantial immune evasion. Although previous study indicated that BNT162b2 messenger RNA vaccine induces potent cross-clade pan-sarbecovirus neutralizing antibodies in survivors of the infection by SARS-CoV-1, the neutralization activity and Fc-mediated effector functions of these cross-reactive antibodies elicited in SARS-CoV-1 survivors to Omicron subvariants still remain largely unknown. In this study, the neutralization activity and Fc-mediated effector functions of antibodies boosted by a third dose vaccination were characterized in SARS-CoV-1 convalescents and healthy individuals. Potent cross-clade broadly neutralizing antibodies were observed in SARS-CoV-1 survivors who received a three-dose vaccination regimen consisting of two priming doses of CoronaVac followed by one booster dose of the protein subunit vaccine ZF2001. However, the induced antibodies exhibited both reduced neutralization and impaired Fc effector functions targeting multiple Omicron subvariants. Importantly, the data also support the notion that immune imprints resulted from SARS-CoV-1 infection may exacerbate the impairment of neutralization activity and Fc-mediated effector functions to Omicron subvariants and provided invaluable information to vaccination strategy in future.

Keywords: ADCC and ADCP; Omicron; SARS-CoV-1; SARS-CoV-2 VOCs; immune imprinting; neutralizing antibodies.

 
Back
Top Bottom